Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 182

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer

Hershman, Dawn, Hall, Michael J., Wang, Xiaoyan, Jacobson, Judith S., McBride, Russell, Grann, Victor R., Neugut, Alfred I. · 2006 · Cancer

Abstract

BACKGROUND.: An important advance in medical oncology has been the use of adjuvant chemotherapy for lymph node‐positive colon cancer. However, to the authors' knowledge, the effect of the interval between surgery and the initiation of chemotherapy on survival has not been investigated. METHODS.: The authors analyzed predictors and outcomes of time intervals to treatment after surgery among patients older than 65 years who were diagnosed with stage III colon cancer between 1992 and 1999 using Surveillance, Epidemiology, and End Results (SEER)‐Medicare data. Linear and logistic regression analyses were used to model predictors of delay, and Cox proportional hazards models were used to analyze the impact of treatment timing on survival. RESULTS.: Among 4382 patients with colon cancer, 1122 patients (26%) began adjuvant chemotherapy within 1 month, 2391 patients (55%) began adjuvant chemotherapy in 1 to 2 months, 454 patients (10%) began adjuvant chemotherapy in 2 to 3 months, and 415 patients (9%) began adjuvant chemotherapy ≥3 months after surgery. Intervals of ≥3 months (delay) were associated with older age, increased comorbid conditions, well/moderately differentiated grade, and being unmarried. Colon cancer‐specific mortality was associated with a delay in the initiation of chemotherapy (hazards ratio [HR], 1.48; 95% confidence interval [95% CI], 1.15–1.92), advanced age, increased comorbidity, poorly differentiated tumor grade, the presence of ≥4 positive lymph nodes, and undergoing surgery in a nonteaching hospital. All‐cause mortality was associated with intervals >2 months between surgery and chemotherapy (2 to 3 months: HR, 1.41; 95% CI, 1.15–1.74; ≥3 months: HR, 1.62; 95% CI, 1.31–1.99) compared with <1 month. CONCLUSIONS.: In the older population that was studied, only 9% of patients initiated adjuvant chemotherapy >3 months after the date of curative surgery. However, delay in initiation was associated with both cancer‐specific and all‐cause mortality. Determining whether these results were because of chemotherapy timing or other associated factors will require further study. Cancer 2006. © 2006 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.22316

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 182

Metadata

Authors
Hershman, D., Hall, M. J., Wang, X., Jacobson, J. S., McBride, R., Grann, V. R., & Neugut, A. I.
Venue
Cancer
Publisher
Wiley
Published
2006-10-31
Volume
107
Issue
11
Pages
2581-2588
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2005231101
Cited by
182
References
3
FWCI
3.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. https://app.cochat.ai/papers/10.1002/cncr.22316
The paper
Hershman, D., Hall, M. J., Wang, X., Jacobson, J. S., McBride, R., Grann, V. R., & Neugut, A. I. (2006). Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. https://doi.org/10.1002/cncr.22316

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.